Patent details

EP3793606 Title: METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS

Basic Information

Publication number:
EP3793606
PCT Application Number:
IB2019054034
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP198039505
PCT Publication Number:
WO2019220369
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS
French Title of Invention:
PROCÉDÉS DE TRAITEMENT DE CANCERS ET D'AMÉLIORATION DE L'EFFICACITÉ D'AGENTS THÉRAPEUTIQUES DE REDIRECTION DE LYMPHOCYTES T
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG VON KREBS UND ZUR STEIGERUNG DER WIRKSAMKEIT VON T-ZELL-UMLEITENDEN THERAPEUTIKA
SPC Number:

Dates

Filing date:
15/05/2019
Grant date:
29/04/2026
EP Publication Date:
24/03/2021
PCT Publication Date:
21/11/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/04/2026
EP B1 Publication Date:
29/04/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/05/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/04/2026
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Name:
Stichting Amsterdam UMC
Address:
De Boelelaan 1117, 1081 HV Amsterdam, Netherlands (NL)

Inventor

1

Name:
FRERICHS, Kris
Address:
Netherlands (NL)

2

Name:
VAN DE DONK, Niels
Address:
Netherlands (NL)

3

Name:
ADAMS, Homer
Address:
United States (US)

4

Name:
GAUDET, Francois
Address:
United States (US)

5

Name:
VERKLEIJ, Christie C.P.M.
Address:
Netherlands (NL)

Priority

1

Priority Number:
201862672222 P
Priority Date:
16/05/2018
Priority Country:
United States (US)

2

Priority Number:
201862736804 P
Priority Date:
26/09/2018
Priority Country:
United States (US)

3

Priority Number:
201962842080 P
Priority Date:
02/05/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61K 45/06; C07K 16/28; C07K 16/30; A61K 31/454; A61K 31/69; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202618
Publication date:
29/04/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
29/06/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages